Global Subcutaneous Immunoglobulin (SCIG) Market Size, Share And Growth Analysis For 2024-2033

The Business Research Company’s Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033

LONDON, GREATER LONDON, UK, July 31, 2024 /EINPresswire.com/ -- The subcutaneous immunoglobulin (SCIG) market has experienced robust growth in recent years, expanding from $11.19 billion in 2023 to $12.72 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of immunodeficiency disorders, rise in the patient preference for home-based care, enhanced therapeutic efficacy, growth in the awareness and diagnosis rates, growth in the favorable reimbursement policies.

Strong Future Growth Anticipated
The subcutaneous immunoglobulin (SCIG) market is projected to continue its strong growth, reaching $21.38 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the growing prevalence of neurological disorders, increasing prevalence of autoimmune diseases, rising awareness and acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, expansion of healthcare facilities.

Explore Comprehensive Insights Into The Global Subcutaneous Immunoglobulin (SCIG) Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15935&type=smp

Growth Driver Of The Subcutaneous Immunoglobulin (SCIG) Market
The increase in the prevalence of secondary immunodeficiency diseases is expected to propel the growth of the subcutaneous immunoglobulin market going forward. Secondary immunodeficiency diseases are conditions with a reduced or compromised immune system caused by sources other than the immune system itself. The prevalence of secondary immunodeficiency diseases is driven by various factors such as aging populations, the use of immunosuppressive treatments, and environmental toxins. Subcutaneous immunoglobulin therapy provides antibodies to help strengthen the weakened immune system, especially in chronic disorders such as HIV or autoimmune diseases, thereby preventing infections and supporting immunological function during treatment.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Major Players And Market Trends
Key players in the subcutaneous immunoglobulin (SCIG) market include Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc.
Major companies operating in the subcutaneous immunoglobulin market are developing subcutaneous human-klhw, a unique formulation containing human immune globulins (Ig) that strengthens the immune system. Subcutaneous human-klhw is used for subcutaneous administration, developed for treating primary immunodeficiency diseases in human body.

Segments:
1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications
3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

Geographical Insights: North America Leading The Market
North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Subcutaneous Immunoglobulin (SCIG) Market Definition
Subcutaneous immunoglobulin (SCIG) refers to a method of administering immunoglobulin therapy in which the medication is delivered under the skin, rather than into a vein. This method allows for slower absorption of the medication, reducing the risk of side effects compared to intravenous administration. SCIG is used to treat various immune deficiencies, providing a convenient and effective way to boost the immune system.

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on subcutaneous immunoglobulin (SCIG) market size, subcutaneous immunoglobulin (SCIG) market drivers and trends, subcutaneous immunoglobulin (SCIG) market major players, subcutaneous immunoglobulin (SCIG) competitors' revenues, subcutaneous immunoglobulin (SCIG) market positioning, and subcutaneous immunoglobulin (SCIG) market growth across geographies. The subcutaneous immunoglobulin (SCIG) market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Autoimmune Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn